10 Jul ALL ALS ASSESS Study
The ASSESS study combines a longitudinal natural history study and biomarker collection for ALS. It aims to make ALS research accessible to everyone, including those who cannot visit academic medical centers, through new technology that allows remote participation. We are looking for people currently living with ALS, individuals who do not have ALS, are not known ALS gene carriers, or at risk of carrying an ALS causative gene to help researchers gain a deeper understanding of ALS and improve future clinical trials.
Participation will consist of in-person and/or remote visits where clinical data such as blood samples and cerebrospinal fluid (optional) will be collected. Participants will also complete speech tasks and questionnaires via our online portal.
Learn more about the ALL ALS study here: https://www.all-als.org/
Participant Eligibility
Who can participate in the ASSESS study?
Individuals currently living with ALS
Control participants including:
– Individuals without ALS or known ALS gene mutations
– Spouses or family members of ALS patients who tested negative for ALS gene mutations
– General population or others encountered at ALS sites
– Must not be at risk of carrying a causative ALS gene mutation
Contact
Lila Brisk
(206) 543-0454
Additional Study Details
Full Study Title
ASSESS ALL ALS study
Investigator(s)
Michael Weiss, MD (Principal Investigator)
Jane Distad, MD
Accepts Healthy Volunteers?
Yes
Study Site(s)
University of Washington Medical Center – Montlake
1959 NE Pacific St, Seattle, WA 98195
Seattle, Washington 98195